- Investing.com
Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions. This segment also provides the ASCENDrive programs for members to receive group purchasing programs, tiers, and prices; SURPASS Performance Group services for coordinate purchasing decisions, review utilization and achieve and maintain standardization across member’s facilities; SaaS informatics products for the purchase additional elements; supply chain co-management services; purchased services contracts; direct sourcing solutions; and supply chain resiliency programs. The Performance Services segment provides technology and services platform with offerings that help optimize performance in three main areas, including clinical intelligence, margin improvement, and value-based care under the PINC AI brand; third party administrator services and management of health benefit programs under the Contigo Health brand; and digital invoicing and payables services that offers financial support services to healthcare product suppliers and service providers under the Remitra brand. The company was incorporated in 2013 and is headquartered in Charlotte, North Carolina.
Supply Chain Triumph | Premier's Supply Chain Services segment outperforms expectations, driving significant revenue and EBITDA growth in Q3 FY2025 |
Margin Mastery | Explore Premier's impressive 9 percentage point gross margin beat, raising questions about sustainability and long-term growth potential |
Strategic Renewals | Delve into the impact of Premier's August 2020 restructure cohort renewals on customer relationships and revenue streams |
Cautious Optimism | Analysts target $24.00 price range amid raised EBITDA guidance, balanced against concerns over purchasing volume sustainability |
Metrics to compare | PINC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPINCPeersSector | |
---|---|---|---|---|
P/E Ratio | 16.5x | 22.5x | −0.5x | |
PEG Ratio | −2.22 | 0.73 | 0.00 | |
Price/Book | 1.2x | 3.3x | 2.6x | |
Price / LTM Sales | 1.4x | 2.0x | 3.2x | |
Upside (Analyst Target) | 5.2% | 47.4% | 42.0% | |
Fair Value Upside | Unlock | 7.6% | 6.6% | Unlock |